Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Business Travel Global Strategic Business Report 2026: Market to Reach $928.4 Billion by 2030 as Bleisure Emerges as a Major Trend Shaping Market Dynamcs